Haemonetics

Haemonetics, founded in 1971, is a global leader in the medical devices and equipment industry. The company specializes in innovative medical products and solutions designed to improve patient care while reducing healthcare costs. Its core technology portfolio focuses on critical medical markets, including blood and plasma component collection, surgical suites, and hospital transfusion services. By maintaining an entrepreneurial culture and a commitment to quality, Haemonetics continues to deliver impactful outcomes for patients worldwide.

Operating with a workforce of 1,000-5,000 employees, Haemonetics maintains a robust operational footprint across 10 global locations. The company leverages advanced manufacturing and R&D capabilities to support its diverse product suite, which includes specialized software and disposable medical systems. Learn about Haemonetics's global headquarters for more information regarding their strategic geographic presence and operational infrastructure in Boston, Massachusetts.

Haemonetics, traded on the NYSE under the ticker HAE, demonstrates significant market presence with annual revenue of $1.4B. The organization competes with major industry players like Terumo BCT and Insulet, consistently driving business optimization through its specialized hematology and blood collection systems. Meet Haemonetics's team to understand the leadership driving these innovations, or Explore financial highlights to review detailed fiscal metrics and recent debt funding activities.